In light of recent cancer immunology research, we can affirm that even though we did not observe any statistically significant association for CD73+ B-cell density, this novel marker should be further investigated in future prospective studies given the fact that CD73 is one of the key enzymes in the signaling pathway of cancers. The gene discussed is NT5E; the disease is cancer.